Indication
Haemophilus influenzae pneumonia
*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains. Read more about Haemophilus influenzae pneumonia
601 drugs 183 manufacturers
Drugs that treat it
Common Haemophilus influenzae pneumonia therapies.
CLARITHROMYCIN
MOXIFLOXACIN HCL
CIPROFLOXACIN HCL
AZITHROMYCIN
AMOXICILLIN
AZITHROMYCIN
CIPROFLOXACIN HCL
AMOXICILLIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains.
The infection predominantly affects young children, older adults, and individuals with immunocompromising conditions or underlying cardiopulmonary diseases such as chronic obstructive pulmonary disease.
Pathophysiologically, the pathogen colonizes the nasopharynx before descending into the tracheobronchial tree, inciting alveolar inflammation, purulent exudate formation, and consolidation.
Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress to bacteremia or respiratory failure.
- nih.gov
*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains
- cdc.gov
*Haemophilus influenzae* pneumonia is an acute lower respiratory tract infection caused by the pleomorphic, gram-negative bacterium *Haemophilus influenzae*, encompassing both encapsulated serotypes (such as type b) and nontypeable unencapsulated strains The infection predominantly affects young children, older adults, and individuals with immunocompromising conditions or underlying cardiopulmonary diseases such as chronic obstructive pulmonary disease
- nih.gov
The infection predominantly affects young children, older adults, and individuals with immunocompromising conditions or underlying cardiopulmonary diseases such as chronic obstructive pulmonary disease Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress to bacteremia or respiratory failure
- nih.gov
The infection predominantly affects young children, older adults, and individuals with immunocompromising conditions or underlying cardiopulmonary diseases such as chronic obstructive pulmonary disease Pathophysiologically, the pathogen colonizes the nasopharynx before descending into the tracheobronchial tree, inciting alveolar inflammation, purulent exudate formation, and consolidation Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress...
- cdc.gov
Pathophysiologically, the pathogen colonizes the nasopharynx before descending into the tracheobronchial tree, inciting alveolar inflammation, purulent exudate formation, and consolidation Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress to bacteremia or respiratory failure
- medlineplus.gov
Pathophysiologically, the pathogen colonizes the nasopharynx before descending into the tracheobronchial tree, inciting alveolar inflammation, purulent exudate formation, and consolidation
- nmhealth.org
Clinically, it manifests with fever, productive cough, dyspnea, and pleuritic chest pain, and it can progress to bacteremia or respiratory failure
Personalize your experience
Follow Haemophilus influenzae pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.